BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35219878)

  • 21. The NAD(+) salvage pathway modulates cancer cell viability via p73.
    Sharif T; Ahn DG; Liu RZ; Pringle E; Martell E; Dai C; Nunokawa A; Kwak M; Clements D; Murphy JP; Dean C; Marcato P; McCormick C; Godbout R; Gujar SA; Lee PW
    Cell Death Differ; 2016 Apr; 23(4):669-80. PubMed ID: 26586573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
    Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
    Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
    Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoring NAD
    Katayoshi T; Nakajo T; Tsuji-Naito K
    J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
    O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
    Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
    Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
    J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
    Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
    Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
    Feng D; Xu D; Murakoshi N; Tajiri K; Qin R; Yonebayashi S; Okabe Y; Li S; Yuan Z; Aonuma K; Ieda M
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD
    Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X
    Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
    Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
    Revollo JR; Grimm AA; Imai S
    Curr Opin Gastroenterol; 2007 Mar; 23(2):164-70. PubMed ID: 17268245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery.
    Tang H; Wang L; Wang T; Yang J; Zheng S; Tong J; Jiang S; Zhang X; Zhang K
    Eur J Med Chem; 2023 Oct; 258():115607. PubMed ID: 37413882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets.
    Indini A; Fiorilla I; Ponzone L; Calautti E; Audrito V
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of proqodine A derivatives with antitumor activity targeting NAD(P)H: quinone oxidoreductase 1 and nicotinamide phosphoribosyltransferase.
    Song J; Zou G; Zhao Z; Zhu Y; Xue J; Ao L; Sun H; Hao H; Zhang B; Xu X
    Chin J Nat Med; 2024 Jan; 22(1):75-88. PubMed ID: 38278561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of NAD
    Ghanem MS; Caffa I; Monacelli F; Nencioni A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tripeptide IRW Upregulates NAMPT Protein Levels in Cells and Obese C57BL/6J Mice.
    Bhullar KS; Son M; Kerek E; Cromwell CR; Wingert BM; Wu K; Jovel J; Camacho CJ; Hubbard BP; Wu J
    J Agric Food Chem; 2021 Feb; 69(5):1555-1566. PubMed ID: 33522796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.
    Sampath D; Zabka TS; Misner DL; O'Brien T; Dragovich PS
    Pharmacol Ther; 2015 Jul; 151():16-31. PubMed ID: 25709099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
    Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
    J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT).
    Audrito V; Managò A; Gaudino F; Deaglio S
    Semin Cell Dev Biol; 2020 Feb; 98():192-201. PubMed ID: 31059816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perturbations of NAD
    Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
    Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.